Related Experiment Video
Updated: May 30, 2026

Cerebral Ischemic Coma Model Induced by Modified Four-Vessel Occlusion
Published on: July 5, 2024
Role of vinpocetine in cerebrovascular diseases
Sazal Patyar1, Ajay Prakash, Manish Modi
1Department of Pharmacology & Neurology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, Chandigarh, India.
Insights
Vinpocetine enhances cerebral blood flow and offers neuroprotection, potentially benefiting cerebrovascular diseases and dementia. Studies suggest it is safe for long-term use as a nootropic supplement.
Area of Science:
- Neurology
- Pharmacology
Background:
- Cerebrovascular accidents (strokes) result from reduced cerebral blood flow (ischemia).
- Chronic cerebral hypoperfusion contributes to irreversible brain damage and dementia.
- Vinpocetine, a vinca alkaloid, demonstrates cerebral blood-flow enhancing and neuroprotective properties.
Purpose of the Study:
- To review studies on vinpocetine's role in cerebrovascular diseases.
- To explore the mechanisms behind vinpocetine's neuroprotective effects.
- To assess the safety and efficacy of vinpocetine for cognitive enhancement.
Main Methods:
- Review of non-clinical and clinical studies on vinpocetine.
- Analysis of research on vinpocetine's impact on cerebral blood flow and metabolism.
- Evaluation of studies investigating vinpocetine's neuroprotective mechanisms.
Main Results:
- Vinpocetine exhibits cerebral blood-flow enhancing effects.
- Neuroprotective mechanisms of vinpocetine have been suggested in various studies.
- Vinpocetine is considered safe for long-term use with no significant reported side effects.
Conclusions:
- Vinpocetine shows promise in managing cerebrovascular diseases.
- Its vasodilatory and nootropic effects support memory improvement.
- Vinpocetine is a safe and effective supplement for enhancing cognitive function and cerebrovascular health.
Abstract:
A cerebrovascular accident, or stroke, is defined as the abrupt onset of a neurological deficit, which can be due to ischemia. Cerebral ischemia is caused by a reduction in blood flow that thereby decreases cerebral metabolism. Chronic cerebral hypoperfusion leads to irreversible brain damage and plays an important role in the development of certain types of dementia. Vinpocetine, chemically known as ethyl apovincaminate, is a vinca alkaloid that exhibits cerebral blood-flow enhancing and neuroprotective effects. Non-clinical and clinical studies have suggested multiple mechanisms responsible for the beneficial neuroprotective effects of vinpocetine. As no significant side effects related to vinpocetine treatment have been reported, it is considered to be safe for long-term use. This vasoactive alkaloid is widely marketed as a supplement for vasodilation and as a nootropic for the improvement of memory. The present review focuses on studies investigating the role of vinpocetine in cerebrovascular diseases.
More Related Videos
08:44Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
Published on: September 1, 2016
06:24Paired Cisterna Magna Nanoinjection and Laser Speckle Contrast Imaging Assay to Study Cerebral Blood Flow Regulation In Vivo
Published on: July 8, 2025
Related Concept Videos
Hemorrhagic Stroke ll: Pathophysiology
Cerebral Edema ll: Pathophysiology
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Hemorrhagic Stroke l: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...